Marion Merrell Dow Inc. (NYSE:MKC) of Kansas City has chosenLatin American Pharmaceutical Inc. (LAPI), a wholly ownedsubsidiary of Dow Chemical Co., as its licensee for LatinAmerica. LAPI will have distribution rights for existing MMDpharmaceutical products and options to select other productsas they are developed. Marketing emphasis will be on Mexico,Brazil and Argentina. Further details of the agreement werenot disclosed.
(c) 1997 American Health Consultants. All rights reserved.